GGrantIndex
Sort

40,608 grants matching prostate cancer

Fast Acousto-Optic Tomography System

$1,010,121
Paul Shnitser · Physical Optics Corporation · R44 · FY2011 · CA

Development

$1,010,066
Ana M Navarro · University Of California, San Diego · U54 · FY2010 · CA

Tissue Processing-Sequencing Facility

$1,009,707
Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

DNA Sequencing

$1,009,684
Steven Akiyama · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES

Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership

$1,009,450
James W Lillard · Morehouse School Of Medicine · U54 · FY2016 · CA

Nuclear Factor-kappaB in Ovarian Cancer

$1,009,250
Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Shanghai Men's Health Study

$1,008,853
Xiao-Ou Shu · Vanderbilt University · UM1 · FY2014 · CA

Development of synthetic sphingolipids for prostate cancer therapy

$1,008,833
Daniel Gil · Siege Pharmaceuticals, Inc. · R44 · FY2020 · CA

1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center

$1,008,781
Romonia Renee Reams · Florida Agricultural And Mechanical Univ · U54 · FY2018 · CA

Identification of epithelial tumor susceptibility genes

$1,008,772
Allan Balmain · University Of California, San Francisco · U01 · FY2007 · CA

(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership

$1,008,742
Olorunseun O Ogunwobi · Hunter College · U54 · FY2021 · CA

PROSTATE, LUNG, COLORECTAL, AND OVARIAN (PLCO) CANCER SCREENING TRIAL - LABORA

$1,008,581
David S Chia · · N01 · FY2007 · CA

FrostBite - A Unique Catheter for Endoscopic Cryoablation

$1,008,442
J M Baust · Cell Preservation Services, Inc. · R44 · FY2017 · CA

HEREDITARY BREAST CANCER--GENETIC AND MOLECULAR STUDIES

$1,008,214
University Of California Irvine · U01 · FY2001 · CA

Robust Predictor of Breast Cancer Risk

$1,008,203
Harry Ostrer · Morgan And Mendel Genomics, Inc. · R42 · FY2021 · CA

(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership

$1,008,081
Olorunseun O Ogunwobi · Hunter College · U54 · FY2019 · CA

Small-molecule therapy for metastatic castration-resistant prostate cancer

$1,007,817
Daqing Wu · Metcure Therapeutics, Llc · R42 · FY2021 · CA

RACE-SPECIFIC 3D COMPUTATIONAL PATHOLOGY BIOMARKERS FOR PREDICTING PROSTATE CANCER-SPECIFIC RECURRENCE

$1,007,685
Emory University · · FY2020 · Defense Health Agency

THE ROLE OF PARP2 IN PROSTATE CANCER

$1,007,624
Brigham & Womens Hospital Inc · · FY2017 · Department of the Army

Biomedical Image Analysis and Informatics

$1,007,609
Matthew McAuliffe · Center For Information Technology · ZIA · FY2017 · CT

EPIGENETIC AGING IN TMPRSS2 FUSION-NEGATIVE AFRICAN AMERICAN PROSTATE CANCER

$1,007,376
Ohio State University, The · · FY2020 · Defense Health Agency

Drug-eluting Brachytherapy Implants for Chemo-radiation Therapy

$1,007,156
Srinivas Sridhar · Theranano, Llc · R42 · FY2019 · CA

Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease

$1,007,034
Rajesh Krishnan · Oncternal Therapeutics, Inc. · R44 · FY2024 · NS

A Novel Optical Spectral Imaging System for Rapid Imaging of Breast Tumor Margins

$1,006,706
Nimmi Ramanujam · Duke University · R01 · FY2013 · EB

Genetic Epidemiology of Lung Cancer

$1,006,509
Marshall W Anderson · University Of Cincinnati · U01 · FY2008 · CA